$3.4099
0.0449[1.33%]
At close: May 2
$3.4099
0[0.00%]
PreMarket: 8:22AM EDT
Aquestive Therapeutics
(NASDAQ:AQST)Aquestive Therapeutics Stock (NASDAQ:AQST), Earnings Estimates, EPS, and Revenue
Aquestive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.080
Quarterly Revenue Estimate
$12.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$50.6M
Analyze the earnings history of Aquestive Therapeutics using advanced sorting and filters.
No data available to display
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|
FAQ
When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?
Aquestive Therapeutics (AQST) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 5, 2024 for Q4.
What were the latest earnings per share (EPS) for Aquestive Therapeutics (NASDAQ:AQST)?
The Actual EPS was $-0.10, which missed the estimate of $-0.08.
What were Aquestive Therapeutics’s (NASDAQ:AQST) revenues?
The Actual Revenue was $13.2M, which beat the estimate of $11.6M.
Browse earnings estimates, EPS, and revenue on all stocks.